Quantum Technology Governance I: Law and Regulation
暫譯: 量子科技治理 I：法律與規範

Mateo Aboy is Director of Research in Biomedical Innovation, AI, QT & Law at the Faculty of Law, University of Cambridge. He is a member of the Centre for Law, Medicine & Life Sciences (LML) and the Centre for IP & Information Law (CIPIL) at the University of Cambridge. He holds degrees in electrical & computer engineering (BS, BSEE, MSECE, MPhil/DEA, PhD ECE), law (LLB, SJD/PhD/LLD), and international management (MBA), as well as professional registrations as a Professional Chartered Engineer (CEng, EU/ES COIT), Certified Licensing Professional (CLP), Patent Practitioner with a Bar Admission/licensed to practice in patent cases before the United States Patent Office (USPTO), Fellow of Information Privacy (FIT, IAPP), Certified Privacy Information Professional (CIPP/E), Certified Privacy Manager (CIPM), Lead Implementer of Information Security Management Systems-ISMS (ISO 27001), Lead Auditor of Medical Device Quality Management Systems (ISO 13485), Lead Implementer of Privacy Information Management Systems - PIMS (ISO 27701), and Certified Data Protection Officer (C-DPO).

Marcelo Corrales Compagnucci is Associate Professor and Associate Director at the Center for Advanced Studies in Bioscience Innovation Law (CeBIL), Faculty of Law, University of Copenhagen in Denmark. He is also Inter-CeBIL Research Affiliate at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. He specializes in information technology, privacy, and data protection law. His research interests are the legal issues involved in disruptive innovation technologies and biomedicine. He wasa research associate with the Institute for Legal Informatics (IRI) at Leibniz Universität Hannover in Germany, and a visiting research fellow in various research centers around the world, including Harvard Law School, Cambridge University, the Max Planck Institute, University of Edinburgh, Turin University, and the Academia Sinica in Taiwan. He has a Doctor of Laws (LL.D.) degree from Kyushu University in Japan. He also holds a Master of Laws (LL.M.) in international economics and business law from Kyushu University, and an LL.M. in law and information technology and an LL.M. in European intellectual property law, both from the University of Stockholm in Sweden.

Timo Minssen is Professor of Law at the University of Copenhagen (UCPH), specializing in Health & Life Science Innovation. He is Director of UCPH's Center for Advanced Studies in Bioscience Innovation Law (CeBIL) and holds the UNESCO Co-Chair in the Right to Science. He is an Inter-CeBIL Research Affiliate at Harvard Law School and the University of Cambridge, and an Associate Member of McGill University's Centre of Genomics and Policy.
His research and practice focus on IP, competition, and regulatory law in emerging technologies, including AI, quantum technologies, advanced health & life science technologies, and biotechnologies. He holds a German law degree from the University of Göttingen and biotech/IP-focused LL.M., M.I.C.L., LL.Lic., and LL.D. degrees from Lund and Uppsala Universities. He has been trained in the German court system, the European Patent Office, and in law firms and start-ups. Previous roles include an Epigenetics fellowship at the Pufendorf Institute for Advanced Studies and visiting professorships at the Technical University of Munich, the Universities of Cambridge and Oxford, Waseda Law School, Harvard Law School, and the Max Planck Institute for Innovation & Competition. In 2007, he was Associate Professor at Chicago-Kent College of Law, teaching comparative European and US patent law.
Timo is a Scientific Advisory Board Member of the Munich Intellectual Property Law Centre (MIPLC) and advises the WHO, WIPO, the European Commission, companies, national governments, and law firms. At UCPH he leads interdisciplinary projects spanning precision medicine, AI-assisted surgery, medical devices and ATMPs, antimicrobial resistance, pandemic preparedness, advanced medical computing, and sustainable innovation. He is PI and grant holder of a large Novo Nordisk Foundation-funded bioscience innovation law program with international core partners including Harvard, DTU, and the Universities of Cambridge and Michigan. His scholarship includes 8 books and 250+ publications and is frequently featured in outlets such as The Economist, Financial Times, El Mundo, Politico, Times of India, WHO Bulletin, and Times Higher Education.

Mateo Aboy 是劍橋大學法學院生物醫學創新、人工智慧、量子科技與法律研究主任。他是劍橋大學法律、醫學與生命科學中心 (Centre for Law, Medicine & Life Sciences, LML) 和知識產權與資訊法中心 (Centre for IP & Information Law, CIPIL) 的成員。他擁有電機與計算機工程 (學士、電機工程學士、電子與計算機工程碩士、哲學碩士/DEA、電子與計算機工程博士)、法律 (法學士、法學博士/博士/法學榮譽博士) 和國際管理 (工商管理碩士) 的學位，並且擁有專業註冊資格，包括專業特許工程師 (CEng, EU/ES COIT)、認證授權專業人員 (CLP)、專利執業者，並獲得在美國專利商標局 (USPTO) 實踐專利案件的律師資格、資訊隱私研究員 (FIT, IAPP)、認證隱私資訊專業人員 (CIPP/E)、認證隱私管理員 (CIPM)、資訊安全管理系統 (ISMS) 的主要實施者 (ISO 27001)、醫療器械品質管理系統的主要審核員 (ISO 13485)、隱私資訊管理系統 (PIMS) 的主要實施者 (ISO 27701) 和認證資料保護官 (C-DPO)。

Marcelo Corrales Compagnucci 是丹麥哥本哈根大學法學院生物科學創新法律高級研究中心 (CeBIL) 的副教授及副主任。他同時也是哈佛法學院健康法律政策、生物技術與生物倫理的彼得里-弗洛姆中心 (Petrie-Flom Center) 的跨CeBIL研究夥伴。他專注於資訊科技、隱私和資料保護法。他的研究興趣包括顛覆性創新技術和生物醫學中的法律問題。他曾在德國漢諾威的法律資訊研究所 (Institute for Legal Informatics, IRI) 擔任研究助理，並在全球多個研究中心擔任訪問研究員，包括哈佛法學院、劍橋大學、馬克斯·普朗克研究所、愛丁堡大學、都靈大學和台灣中央研究院。他擁有日本九州大學的法學博士 (LL.D.) 學位，並在九州大學獲得國際經濟與商法的法學碩士 (LL.M.)，以及在瑞典斯德哥爾摩大學獲得法律與資訊科技的法學碩士 (LL.M.) 和歐洲知識產權法的法學碩士 (LL.M.)。

Timo Minssen 是哥本哈根大學 (UCPH) 的法律教授，專注於健康與生命科學創新。他是UCPH生物科學創新法律高級研究中心 (CeBIL) 的主任，並擔任聯合國教科文組織科學權利的共同主席。他是哈佛法學院和劍橋大學的跨CeBIL研究夥伴，以及麥吉爾大學基因組學與政策中心的副會員。他的研究和實踐專注於新興技術中的知識產權、競爭和監管法，包括人工智慧、量子技術、高級健康與生命科學技術以及生物技術。他擁有德國哥廷根大學的法律學位，並在隆德大學和烏普薩拉大學獲得以生物技術/知識產權為重點的法學碩士 (LL.M.)、國際商法碩士 (M.I.C.L.)、法學學位 (LL.Lic.) 和法學博士 (LL.D.) 學位。他接受過德國法院系統、歐洲專利局以及律師事務所和初創公司的培訓。之前的職位包括在普芬多夫高級研究所的表觀遺傳學研究獎學金，以及在慕尼黑工業大學、劍橋大學、牛津大學、早稻田法學院、哈佛法學院和馬克斯·普朗克創新與競爭研究所的訪問教授。2007年，他在芝加哥-肯特法學院擔任副教授，教授比較歐洲和美國專利法。Timo 是慕尼黑知識產權法中心 (MIPLC) 的科學諮詢委員會成員，並為世界衛生組織 (WHO)、世界知識產權組織 (WIPO)、歐洲委員會、公司、國家政府和律師事務所提供建議。在UCPH，他領導跨學科項目，涵蓋精準醫療、人工智慧輔助手術、醫療器械和ATMPs、抗微生物抗藥性、疫情準備、高級醫療計算和可持續創新。他是由Novo Nordisk Foundation資助的大型生物科學創新法律計劃的主要研究者和資助持有者，核心國際合作夥伴包括哈佛大學、丹麥科技大學 (DTU) 和劍橋大學及密西根大學。他的學術成果包括8本書籍和250多篇出版物，經常出現在《經濟學人》、《金融時報》、《世界報》、《政治家》、《印度時報》、《世界衛生組織公報》和《高等教育時報》等媒體上。